<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000468778"><TermName>aprepitant</TermName><TermPronunciation>(uh-PREH-pih-tunt)</TermPronunciation><TermDefinition><DefinitionText>A drug used together with other drugs to prevent and control the nausea and vomiting caused by cancer treatment. It is also used to treat nausea and vomiting after surgery. It is a type of antiemetic and a type of substance P/neurokinin 1 receptor antagonist. Also called Emend.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000716823" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;aprepitant&quot;" language="en" id="_3"/><MediaLink ref="CDR0000716822" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;aprepitant&quot;" language="es" id="_4"/><SpanishTermName>aprepitant</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa junto con otros para prevenir y controlar la náusea y el vómito causados por el tratamiento de cáncer. También se usa para tratar la náusea y diarrea después de la cirugía. Es un tipo de antiemético y un tipo de antagonista del receptor de la sustancia P o neuroquinina 1. También se llama Emend.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-10-14</DateFirstPublished><DateLastModified>2010-01-11</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000500177">Aprepitant</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
